Point of Care Diagnostics Market 2025–2033: COVID-19 & Beyond

According to FutureWise analysis, the point of care diagnostics market in 2025 is US$51.19 billion, and is expected to reach US$88.75 billion by 2033 at a CAGR of 7.12%. The point-of-care diagnostics market is experiencing a significant transformation driven by the growing global demand for faster and more accessible healthcare solutions. Recent innovations in portable testing devices, real-time disease detection, and AI-integrated diagnostics are improving patient care in both remote and clinical environments. This rapid development reflects a broader trend towards decentralized, efficient, and patient-centered healthcare delivery, aimed at enhancing outcomes and accessibility for patients.

Key growth drivers: Increasing demand for rapid molecular tests, multiplex respiratory and STI panels, digital integration with electronic medical records, and expansion into outpatient and low-resource settings.

Challenges: Post-COVID adjustments, increased regulatory scrutiny (particularly for over-the-counter and home molecular tests), and consolidation among vendors.

Molecular POC growth – Fast and accurate NAAT platforms are being increasingly utilized at the bedside.

Digital & connected diagnostics – Integrating with mobile apps and electronic medical records (EMRs) is a crucial differentiating factor.

Point-of-care diagnostics (POCT) involves conducting medical diagnostic tests and analyses at or near the location where a patient receives care. This can be at the bedside, in a clinic, at a community health center, or even in non-traditional healthcare settings like pharmacies. POCT eliminates the need to transport samples to centralized laboratories, which significantly reduces the time between sample collection and the availability of results. Because of its quick results and versatility, POCT is used in various healthcare settings, ranging from hospitals and clinics to remote areas and community centers. The accessibility and cost-effectiveness of point-of-care testing make it a valuable tool, especially in resource-limited environments where timely diagnosis is crucial. However, to fully realize the potential of this approach, it is essential to ensure the accuracy of results, provide proper training for healthcare staff, and carefully consider costs. Overall, point-of-care diagnostics represent a significant advancement in healthcare delivery, equipping both patients and healthcare professionals with immediate, actionable information that can lead to improved patient outcomes.

 FutureWise Market Research has instantiated a report that provides an intricate analysis of Point of Care Diagnostics Market trends that shall affect the overall market growth.

Request a Free Sample @

https://www.futurewiseresearch.com/contact.aspx?rpt=3441&type=requestsample

By Product

• Glucose Monitoring Products
  • Strips
  • Meters
  • Lancets and Lancing Platform
• Cardiometabolic Testing Products
  • Cardia Marker Testing Products
  • Blood Gas/Electrolytes Testing Products
  • HBA1C Testing Products
• Infectious Disease Testing Products
  • HIV testing Products
  • Hepatitis C Testing Products
  • Sexually Transmitted Disease (STD) Testing Products
  • Healthcare-Associated Infection (HAI) Testing Products
  • Respiratory Infection Testing Products
  • Tropical Disease Testing Products
  • Other Infectious Disease Testing Products
• Coagulation Testing Products
  • PT/INR Testing Products
  • Activated Clotting Time (ACT/APTT) Testing Products
• Pregnancy and Fertility Testing Products
  • Tumour/Cancer Marker Testing Products
  • Urinalysis Testing Products
  • Cholesterol Testing Products
  • Hematology testing Products
  • Drug-of-Abuse Testing Products
  • Fecal Occult Testing Products
  • Other POC Products

By Platform

• Agglutination Assays
• Immunoassays
• Biosensors
• Dipsticks
• Lateral Flow Assays
• Microfluidics
• Molecular Diagnostics
• Solid Phase

By Mode

• Prescription-Based Testing
• OTC Testing

By End User

• Home Care/ Self Testing
• Physician Offices and Outpatient Centers
• Hospitals
• Research Laboratories
• Other End Users

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Point of Care Diagnostics Market:

• Abbott
• AccuBioTech
• BioMérieux SA
• Bio-Rad Laboratories
• Becton Dickinson, and Company
• Chembio Diagnostics
• Danaher
• EKF Diagnostics
• F. Hoffmann-La Roche
• Werfen (Instrumentation Laboratory)
• Johnson & Johnson
• Nova
• PTS Diagnostics
• Sekisui Diagnostic
• Siemens Healthineers
• Sinocare Inc.
• Sysmex Corporation
• Trinity Biotech
• Trividia Health Inc.,0
• QIAGEN
• Quidel

Recent developments by key players in the Point of Care Diagnostics Market:

Abbott

• In April 2024, Abbott's i-STAT TBI cartridge, designed for detecting traumatic brain injuries, received FDA clearance for the use of direct whole blood, enhancing rapid on-site neurological assessment capabilities.
• The company maintains its leadership in the POC market with approximately 23% market share projected for 2024, offering a robust portfolio that includes glucose monitoring, ID NOW molecular assays, and CRP testing.
• The company is expanding its ID NOW rapid molecular platform, which provides results in just 13 minutes.
• The company has enhanced its portfolios for respiratory and strep testing.

Siemens Healthineers

• Siemens has integrated AI analytics into its POC devices, such as handheld troponin and blood gas analyzers, enhancing diagnostic accuracy and making them compatible with smartphones and the cloud.
• The RAPIDPoint, Epoc, and DCA product lines are expanding in hospitals and emergency services.

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=3441&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Point of Care Diagnostics Market By Product, By Platform, By Mode, By End User and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: [email protected]